<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Azenta Inc — News on 6ix</title>
<link>https://6ix.com/company/azenta-inc</link>
<description>Latest news and press releases for Azenta Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/azenta-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354aa778dffbe2df0e4c3b.webp</url>
<title>Azenta Inc</title>
<link>https://6ix.com/company/azenta-inc</link>
</image>
<item>
<title>Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast</guid>
<pubDate>Wed, 29 Apr 2026 20:05:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2026 earnings which ended on March 31, 2026, on Wednesday, May 6, 2026, before the market opens.</description>
</item>
<item>
<title>Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-life-sciences-announces-leadership-transition-to-accelerate-gene-synthesis-strategy-and-multiomics-execution</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-life-sciences-announces-leadership-transition-to-accelerate-gene-synthesis-strategy-and-multiomics-execution</guid>
<pubDate>Tue, 07 Apr 2026 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 7, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics</description>
</item>
<item>
<title>Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-completes-strategic-acquisition-of-uk-biocentre-limited-to-expand-biorepository-capabilities</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-completes-strategic-acquisition-of-uk-biocentre-limited-to-expand-biorepository-capabilities</guid>
<pubDate>Wed, 04 Mar 2026 14:11:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon the completion of certain milestones.</description>
</item>
<item>
<title>Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-to-participate-in-raymond-james-47th-annual-institutional-investor-conference</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-to-participate-in-raymond-james-47th-annual-institutional-investor-conference</guid>
<pubDate>Tue, 24 Feb 2026 21:05:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond James 47th Annual Institutional Investor Conference, on Tuesday March 3rd, 2026, which includes a presentation beginning at 4:00 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.</description>
</item>
<item>
<title>Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-life-sciences-frontier-space-210500901</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-life-sciences-frontier-space-210500901</guid>
<pubDate>Mon, 09 Feb 2026 21:05:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in life sciences, including participation in the recently launched EGGS-2 (Early Gen micro-Gravity Service) mission, developed in collaboration with Orbital Paradigm. The mis</description>
</item>
<item>
<title>Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-reports-first-quarter-results-113000435</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-reports-first-quarter-results-113000435</guid>
<pubDate>Wed, 04 Feb 2026 11:30:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.</description>
</item>
<item>
<title>Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2026-first-210500219</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2026-first-210500219</guid>
<pubDate>Wed, 21 Jan 2026 21:05:00 GMT</pubDate>
<description>Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before the market opens.</description>
</item>
<item>
<title>Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-enters-definitive-agreement-sale-its-b-medical-systems-business-thelema-sa-rl</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-enters-definitive-agreement-sale-its-b-medical-systems-business-thelema-sa-rl</guid>
<pubDate>Mon, 29 Dec 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding</description>
</item>
<item>
<title>Azenta Authorizes $250 Million Share Repurchase Program</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-authorizes-250-million-share-repurchase-program-2025-12-10</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-authorizes-250-million-share-repurchase-program-2025-12-10</guid>
<pubDate>Wed, 10 Dec 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase</description>
</item>
<item>
<title>Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-reports-fourth-quarter-and-full-year-fiscal-2025-results-ended-september-30</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-reports-fourth-quarter-and-full-year-fiscal-2025-results-ended-september-30</guid>
<pubDate>Fri, 21 Nov 2025 05:00:00 GMT</pubDate>
<description>Q4'25 reported revenue growth of 6% year over year and 4% on an organic basisFY'25 reported revenue growth of 4% and 3% on an organic basisFY'25 Adjusted</description>
</item>
<item>
<title>Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-fourth-quarter-and-full-year-conference-call-and-webcast</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-fourth-quarter-and-full-year-conference-call-and-webcast</guid>
<pubDate>Wed, 12 Nov 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on</description>
</item>
<item>
<title>Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-life-sciences-partners-precede-foundation-advance-early-detection-pancreatic</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-life-sciences-partners-precede-foundation-advance-early-detection-pancreatic</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an</description>
</item>
<item>
<title>Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-host-investor-day-its-biorepository-facility-indianapolis-indiana-2025-10-15</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-host-investor-day-its-biorepository-facility-indianapolis-indiana-2025-10-15</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10,</description>
</item>
<item>
<title>Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-reports-third-quarter-results-fiscal-2025-ended-june-30-2025-reiterates-full</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-reports-third-quarter-results-fiscal-2025-ended-june-30-2025-reiterates-full</guid>
<pubDate>Tue, 05 Aug 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025. The</description>
</item>
<item>
<title>Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-life-sciences-partners-frenova-division-fresenius-medical-care-and</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-life-sciences-partners-frenova-division-fresenius-medical-care-and</guid>
<pubDate>Thu, 31 Jul 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of</description>
</item>
<item>
<title>Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-participate-10th-annual-needham-virtual-medtech-diagnostics-1x1-conference</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-participate-10th-annual-needham-virtual-medtech-diagnostics-1x1-conference</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual</description>
</item>
<item>
<title>Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-third-quarter-earnings-conference-call-and-webcast-2025</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-third-quarter-earnings-conference-call-and-webcast-2025</guid>
<pubDate>Wed, 23 Jul 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on</description>
</item>
<item>
<title>Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-life-sciences-and-form-bio-announce-strategic-partnership-advance-aav-gene</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-life-sciences-and-form-bio-announce-strategic-partnership-advance-aav-gene</guid>
<pubDate>Tue, 13 May 2025 04:00:00 GMT</pubDate>
<description>Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass.,</description>
</item>
<item>
<title>Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-reports-second-quarter-results-fiscal-2025-ended-march-31-2025-2025-05-07</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-reports-second-quarter-results-fiscal-2025-ended-march-31-2025-2025-05-07</guid>
<pubDate>Wed, 07 May 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025. The</description>
</item>
<item>
<title>Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast</title>
<link>https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-second-quarter-earnings-conference-call-and-webcast-2025</link>
<guid isPermaLink="true">https://6ix.com/company/azenta-inc/news/azenta-announces-fiscal-2025-second-quarter-earnings-conference-call-and-webcast-2025</guid>
<pubDate>Thu, 24 Apr 2025 04:00:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025,</description>
</item>
</channel>
</rss>